Heparin and the peritoneal membrane.
Margetts
Peter
P
Division of Nephrology, St. Joseph's Hospital, Department of Medicine, McMaster University Hamilton, Ontario, Canada. margetts@mcmaster.ca
D000818:Animals; D000925:Anticoagulants / Q000008:administration & dosage* / Q000493:pharmacokinetics; D015314:Dialysis Solutions / Q000494:pharmacology*; D004338:Drug Combinations; D006493:Heparin / Q000008:administration & dosage* / Q000493:pharmacokinetics; D006801:Humans; D010530:Peritoneal Dialysis / Q000009:adverse effects / Q000379:methods*; D010532:Peritoneal Diseases / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control*; D010537:Peritoneum / Q000187:drug effects / Q000378:metabolism*; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control
D000925:Anticoagulants; D015314:Dialysis Solutions; D004338:Drug Combinations; D006493:Heparin